Ernexa Therapeutics (ERNAW) FCF Margin (2010 - 2024)
Ernexa Therapeutics (ERNAW) reported FCF Margin of 18657.89% for Q4 2024, down 910687.0% on a YoY basis from N/an in Q1 2024, and down 1341.37% quarter-over-quarter from 1294.46% in Q3 2024.
Ernexa Therapeutics (ERNAW) FCF Margin (2010 - 2024) Analysis & Trends
Ernexa Therapeutics has reported FCF Margin for 13 years, with the latest figure at 18657.89% in Q4 2024.
- For the quarter ending Q4 2024, FCF Margin fell 910687.0% year-over-year to 18657.89%; the trailing twelve-month figure through Dec 2024 stood at 2700.83% (up 1772617.0% YoY), and the FY2024 full-year result was 2700.83%, up 1772617.0% from the prior year.
- FCF Margin for Q4 2024 stood at 18657.89%, down from 1294.46% in the prior quarter.
- The five-year high for FCF Margin was 78.43% in Q1 2020, with the low at 18657.89% in Q4 2024.
- Historically, FCF Margin has averaged 6092.51% across 3 years, with a median of 5336.17% in 2024.
- The largest YoY upside for FCF Margin was 1012907 bps in 2024 against a maximum downside of 910687 bps in 2024.
- Ernexa Therapeutics' FCF Margin stood at 142.7% in 2020, then plunged by 6593 bps to 9551.02% in 2023, then plunged by 95 bps to 18657.89% in 2024.
- The last three FCF Margin figures came in at 18657.89% (Q4 2024), 1294.46% (Q3 2024), and 5336.17% (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ernexa Therapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -18,657.89% |
| Sep 30, 2024 | -1,294.46% |
| Jun 30, 2024 | -5,336.17% |
| Mar 31, 2024 | -8,187.23% |
| Dec 31, 2023 | -9,551.02% |
| Sep 30, 2023 | -11,423.53% |
| Dec 31, 2020 | -142.70% |
| Sep 30, 2020 | -161.17% |
| Mar 31, 2020 | -78.43% |
| Dec 31, 2019 | 17.40% |
| Sep 30, 2019 | 3.91% |
| Jun 30, 2019 | 5.26% |
| Mar 31, 2019 | 8.80% |
| Dec 31, 2018 | 2.77% |
| Sep 30, 2018 | 4.63% |
| Jun 30, 2018 | 4.99% |
| Mar 31, 2018 | -5.61% |
| Dec 31, 2017 | -7.91% |
| Sep 30, 2017 | -37.40% |
| Jun 30, 2017 | 55.18% |